4.5 Article

Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine

期刊

VACCINE
卷 33, 期 11, 页码 1360-1368

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.01.047

关键词

Dengue virus; Envelope protein; Mass spectrometry; N-glycosylation

向作者/读者索取更多资源

Recently, several virus studies have shown that protein glycosylation play a fundamental role in the virus-host cell interaction. Glycosylation characterization of the envelope proteins in both insect and mammalian cell-derived dengue virus (DENV) has established that two potential glycosylation residues, the asparagine 67 and 153 can potentially be glycosylated. Moreover, it appears that the glycosylation of these two residues can influence dramatically the virus production and the infection spreading in either mosquito or mammalian cells. The Sanofi Pasteur tetravalent dengue vaccine (CYD) consists of four chimeric viruses produced in mammalian vero cells. As DENV, the CYDs are able to infect human monocyte-derived dendritic cells in vitro via C-type lectins cell-surface molecules. Despite the importance of this interaction, the specific glycosylation pattern of the DENV has not been clearly documented so far. In this paper, we investigated the structure of the N-linked glycans in the four CYD serotypes. Using MALDI-TOF analysis, the N-linked glycans of CYDs were found to be a mix of high-mannose, hybrid and complex glycans. Site-specific N-glycosylation analysis of CYDs using nanoLC-ESI-MS/MS demonstrates that both asparagine residues 67 and 153 are glycosylated. Predominant glycoforms at asparagine 67 are high mannose-type structures while mainly complex- and hybrid-type structures are detected at asparagine 153. In vitro studies have shown that the immunological consequences of infection by the CYD dengue viruses 1-4 versus the wild type parents are comparable in human monocyte-derived dendritic cells. Our E-protein glycan characterizations of CYD are consistent with those observations from the wild type parents and thus support in vitro studies. In addition, these data provide new insights for the role of glycans in the dengue virus-host cell interactions. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey

Guillaume Ravel, Nathalie Mantel, Jeremy Silvano, Alexandra Rogue, Bruno Guy, Nicholas Jackson, Nicolas Burdin

VACCINE (2017)

Article Biochemical Research Methods

Replacement of primary monkey kidney cells by L20B cell line in the test for effective inactivation of inactivated poliovirus vaccine

Cynthia Chapel, Nathalie Rocher-Helion, Nathalie Mantel, Sandy Imbert, Eric Deshaies, Veronique Barban, Alain Sabouraud, Jean-Philippe Barbe, Laurent Mallet

JOURNAL OF VIROLOGICAL METHODS (2018)

Article Virology

Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and-4

Veronique Barban, Nathalie Mantel, Aymeric De Montfort, Anke Pagnon, Fabrine Pradezynski, Jean Lang, Florence Boudet

JOURNAL OF VIROLOGY (2018)

Article Public, Environmental & Occupational Health

Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model

Bruno Guy, Veronique Barban, Nathalie Mantel, Marion Aguirre, Sandrine Gulia, Jeremy Pontvianne, Therese-Marie Jourdier, Laurence Ramirez, Veronique Gregoire, Christophe Charnay, Nicolas Burdin, Rafaele Dumas, Jean Lang

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)

Article Biochemical Research Methods

Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines

N. Mantel, M. Aguirre, S. Gulia, Y. Girerd-Chambaz, S. Colombani, C. Moste, V. Barban

JOURNAL OF VIROLOGICAL METHODS (2008)

Article Immunology

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses

N. Mantel, Y. Girerd, C. Geny, I. Bernard, J. Pontvianne, J. Lang, V. Barban

VACCINE (2011)

Article Public, Environmental & Occupational Health

Evaluation of Chimeric Yellow Fever 17D/Dengue Viral Replication in Ticks

Maria Kazimirova, Nathalie Mantel, Sandrine Raynaud, Mirko Slovak, Katarina Ustanikova, Jean Lang, Bruno Guy, Veronique Barban, Milan Labuda

VECTOR-BORNE AND ZOONOTIC DISEASES (2012)

Article Virology

Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric Yellow Fever 17D/Dengue viruses

Veronique Barban, Jorge L. Munoz-Jordan, Gilberto A. Santiago, Nathalie Mantel, Yves Girerd, Sandrine Gulia, Jean-Baptiste Claude, Jean Lang

VIROLOGY (2012)

Article Immunology

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models

Fabienne Piras-Douce, Franck Raynal, Alix Raquin, Yves Girerd-Chambaz, Sylviane Gautheron, Martha Erika Navarro Sanchez, Manuel Vangelisti, Nathalie Mantel

Summary: vYF-247, a live-attenuated yellow fever vaccine candidate, demonstrated low neurovirulence, neurotropism, viscerotropism, and comparable immunogenicity to Stamaril and YF-VAX in relevant animal models. In animal studies, vYF-247 provided protection against yellow fever virus and showed promising results as a potential vaccine candidate.

VACCINE (2021)

暂无数据